Moderna, Inc. settles LNP patent dispute for $950M, securing royalty-free tech access and legal clarity; click for what it ...

CHMP adopts positive opinion on Moderna’s mRNA combination vaccine ‘mCOMBRIAX’ against influenza, Covid-19: Cambridge, Massachusetts Wednesday, March 4, 2026, 16:00 Hrs [IST ...

Moderna will pay up to $2.25B to settle a patent lawsuit over lipid nanoparticle technology used in its COVID-19 vaccine.

As the midterm elections approach, the health secretary is focusing on “real food.” Anger is rising among some of his supporters.

COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...

The Atlantic recently published a profile of Del Bigree titled ‘I Genuinely Am Upset That Your Kids Are Vaccinated’. “Del Bigtree, a longtime ally of Robert F. Kennedy Jr., isn’t just anti-vaccine. He ...

Moderna has managed to eke out some temporary wins, paving the way for the homegrown biotech to focus on its next moves.

A recent study shows how scientists try to assess vaccines honestly, then improve them incrementally — offering a solid ...

By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...

Moderna agreed to pay up to $2.25 billion to settle a long‑running COVID vaccine patent dispute. The deal ends years of legal challenges.

Federal investment in RNA vaccine research has supported nearly three decades of scientific work spanning infectious diseases, cancer, and vaccine development, but recent and proposed funding cuts ...

European regulators advanced several new medicines, including a combined flu and COVID vaccine and new treatments for rare diseases.